A framework for measurement and harmonization of pediatric multiple sclerosis etiologic research studies: The

Sandra Magalhaes1, Brenda Banwell2, Amit Bar-Or3

  • 1Royal Victoria Hospital, Allan Memorial Institute and Neuroepidemiology Research Unit, Research Institute of the McGill University Health Centre, Montreal, QC, Canada/Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|June 23, 2018
PubMed

Insights

This study presents the Pediatric MS Tool-Kit, a framework for assessing environmental tobacco smoke (ETS) exposure, sun exposure, and vitamin D intake in pediatric multiple sclerosis (MS) studies. The kit aims to improve data comparability and overcome sample size limitations.

Area of Science:

  • Pediatric Neurology
  • Epidemiology
  • Environmental Health

Background:

  • Studying the etiology of pediatric multiple sclerosis (MS) presents unique methodological advantages but is often limited by small sample sizes.
  • Accurate assessment of etiological risk factors is crucial for understanding MS development in children.

Purpose of the Study:

  • To develop a standardized measurement framework, the Pediatric MS Tool-Kit, for assessing key etiological risk factors in pediatric MS.
  • To enhance the comparability and harmonization of data across pediatric MS studies, thereby addressing limitations posed by small sample sizes.

Main Methods:

  • A Delphi study involving international experts in epidemiology, neurology, and content analysis was conducted.
  • Input was solicited from the International Pediatric MS Study Group to identify critical risk factors: environmental tobacco smoke (ETS) exposure, sun exposure, and vitamin D intake.

Main Results:

  • The Pediatric MS Tool-Kit comprises six core variables for measuring ETS exposure, six for sun exposure, and six for vitamin D intake.
  • The Tool-Kit is accessible online, providing a readily available resource for researchers.

Conclusions:

  • The Pediatric MS Tool-Kit is designed to improve exposure measurement and comparability in new pediatric MS studies.
  • This framework facilitates study harmonization, offering a strategy to overcome challenges associated with small sample sizes in pediatric MS etiology research.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
320
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
239
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305
Harmonic Mean01:09

Harmonic Mean

The arithmetic mean is usually skewed towards the larger values in the data set. Therefore, to avoid this inherent bias towards smaller values, the harmonic mean is used.
Take the example of the speed of a car, which is the measure of the rate of distance traveled. If the vehicle traverses the same distance back-and-forth, its average speed equals the total distance traveled divided by the total time taken. However, if the car moves with varying speeds, then the arithmetic mean is more skewed...
3.8K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
570